[go: up one dir, main page]

DK0514415T3 - Drivgasblandinger og deres anvendelse i lægemiddelpræparater - Google Patents

Drivgasblandinger og deres anvendelse i lægemiddelpræparater

Info

Publication number
DK0514415T3
DK0514415T3 DK91903275T DK91903275T DK0514415T3 DK 0514415 T3 DK0514415 T3 DK 0514415T3 DK 91903275 T DK91903275 T DK 91903275T DK 91903275 T DK91903275 T DK 91903275T DK 0514415 T3 DK0514415 T3 DK 0514415T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
propellant mixtures
propellant
mixtures
preparations
Prior art date
Application number
DK91903275T
Other languages
Danish (da)
English (en)
Inventor
Hans-Hermann Weil
Ottfried Daab
Original Assignee
Boehringer Ingelheim Pharma
Boehringer Ingelheim Kg
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6399400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0514415(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma, Boehringer Ingelheim Kg, Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK0514415T3 publication Critical patent/DK0514415T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00—Materials not provided for elsewhere
    • C09K3/30—Materials not provided for elsewhere for aerosols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
DK91903275T 1990-02-03 1991-01-31 Drivgasblandinger og deres anvendelse i lægemiddelpræparater DK0514415T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4003272A DE4003272A1 (de) 1990-02-03 1990-02-03 Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
PCT/EP1991/000177 WO1991011495A1 (fr) 1990-02-03 1991-01-31 Nouveaux melanges de gaz propulseurs et leur utilisation dans des preparations medicamenteuses

Publications (1)

Publication Number Publication Date
DK0514415T3 true DK0514415T3 (da) 1998-10-07

Family

ID=6399400

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91903275T DK0514415T3 (da) 1990-02-03 1991-01-31 Drivgasblandinger og deres anvendelse i lægemiddelpræparater

Country Status (24)

Country Link
US (1) US6413497B1 (fr)
EP (1) EP0514415B1 (fr)
JP (1) JP3497161B2 (fr)
AT (1) ATE165863T1 (fr)
AU (1) AU650001B2 (fr)
CA (1) CA2075058C (fr)
CZ (1) CZ286691B6 (fr)
DE (2) DE4003272A1 (fr)
DK (1) DK0514415T3 (fr)
ES (1) ES2117964T3 (fr)
FI (1) FI102905B (fr)
HK (1) HK1010786A1 (fr)
HR (1) HRP940735B1 (fr)
HU (2) HU9202509D0 (fr)
IE (2) IE910350A1 (fr)
IL (1) IL97028A (fr)
NO (1) NO302419B1 (fr)
NZ (1) NZ236973A (fr)
PT (1) PT96634B (fr)
SI (1) SI9110156B (fr)
SK (1) SK280426B6 (fr)
WO (1) WO1991011495A1 (fr)
YU (1) YU49203B (fr)
ZA (1) ZA91754B (fr)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5776434A (en) * 1988-12-06 1998-07-07 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
CA2086096A1 (fr) * 1990-06-27 1991-12-28 Robert A. Moris Utilisation de fluorosurfactants pour la preparation de formulations pour inhalateurs doseurs en aerosol
WO1992006675A1 (fr) * 1990-10-18 1992-04-30 Minnesota Mining And Manufacturing Company Formulation d'aerosol contenant du beclomethasone 17,21 dipropionate
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
GB9024366D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
HU205249B (en) * 1990-11-09 1992-04-28 Egyt Gyogyszervegyeszeti Gyar Process for producing suspensive aerosole composition
US5725791A (en) * 1991-03-28 1998-03-10 E. I. Du Pont De Nemours And Company Azeotropic and azeotrope-like compositions of 1,1,2,2-tetrafluoroethane
US5182040A (en) * 1991-03-28 1993-01-26 E. I. Du Pont De Nemours And Company Azeotropic and azeotrope-like compositions of 1,1,2,2-tetrafluoroethane
DE69233659T2 (de) * 1991-06-10 2007-09-13 Schering Corp. Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
ATE134509T1 (de) * 1991-06-10 1996-03-15 Schering Corp Fluorchlorkohlenwasserstoffreie aerosolformulierungen
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
AU663905B2 (en) * 1991-12-12 1995-10-26 Glaxo Group Limited Medicaments
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
US5916540A (en) * 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
DK0616525T3 (da) * 1991-12-12 1996-01-08 Glaxo Group Ltd Medikamenter
US20030103907A1 (en) * 1991-12-18 2003-06-05 Schultz Robert K. Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
DE69232034T2 (de) 1991-12-18 2002-06-06 Minnesota Mining And Mfg. Co., Saint Paul Aerosolzusammensetzungen für Arzneimittelsuspensionen
DE4203306A1 (de) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh Asthma oder pulmonal-aerosolzubereitungen mit lecithin
DE4230876A1 (de) 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
WO1993022221A1 (fr) * 1992-05-04 1993-11-11 Minnesota Mining And Manufacturing Company Dispositif d'emission d'un aerosol
DE4218291A1 (de) * 1992-06-03 1993-12-09 Mattern Et Partner Pharmazeuti Dosierspray für pernasale Applikation
US5833950A (en) * 1992-07-31 1998-11-10 Glaxo Group Limited Aerosol formulations containing beclomethasone dipropionate-1, 1, 1, 2-tetrafluoroethane solvate
WO1994004629A1 (fr) * 1992-08-21 1994-03-03 E.I. Du Pont De Nemours And Company Melanges a point d'ebulition sensiblement constant de 1,1,1,2-tetrafluoroethane, d'ether dimethylique et d'isobutane
ES2129117T3 (es) * 1992-12-09 1999-06-01 Boehringer Ingelheim Pharma Formulaciones en disolucion en forma de aerosol medicinales estabilizadas.
US5458798A (en) 1993-02-05 1995-10-17 E. I. Du Pont De Nemours And Company Azeotropic and azeotrope-like compositions of a hydrofluorocarbon and a hydrocarbon
US5474758A (en) * 1993-07-28 1995-12-12 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
WO1995017195A1 (fr) * 1993-12-20 1995-06-29 Minnesota Mining And Manufacturing Company Compositions d'aerosols a base de flunisolide
CH686806A5 (de) * 1994-01-12 1996-06-28 Cerberus Ag Gasgemisch zur Funktionspruefung von Rauchmeldern.
US6001273A (en) 1994-03-11 1999-12-14 Minor; Barbara Haviland Binary azeotropes of difluoromethane and hydrocarbons
US5417871A (en) * 1994-03-11 1995-05-23 E. I. Du Pont De Nemours And Company Hydrofluorocarbon compositions
GB9419536D0 (en) * 1994-09-28 1994-11-16 Glaxo Inc Medicaments
EE9700138A (et) * 1994-12-22 1997-12-15 Astra Aktiebolag Aerosoolravimvormid
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US6013245A (en) * 1995-01-26 2000-01-11 Glaxo Group Limited Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant
GB9507768D0 (en) * 1995-04-13 1995-05-31 Glaxo Group Ltd Method of apparatus
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9620187D0 (en) * 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
DK1014943T3 (da) 1997-02-05 2002-10-14 Jago Res Ag Medicinske aerosolformuleringer
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
GB9805938D0 (en) 1998-03-19 1998-05-13 Glaxo Group Ltd Valve for aerosol container
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6585958B1 (en) 1998-07-24 2003-07-01 Jago Research Ag Medicinal aerosol formulations
WO2000007567A1 (fr) 1998-08-04 2000-02-17 Jago Research Ag Formulations d'aerosol a usage medical
US6458338B1 (en) * 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
BR0011343A (pt) 1999-06-05 2002-03-12 Innovata Biomed Ltd Dispositivo de distribuição de medicamento,e,métodos de administrar um medicamento por inalação,e de,tratamento de um paciente com distúrbio respiratório
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
US7217409B2 (en) 2000-09-22 2007-05-15 Smithkline Beecham Corporation Alkanoic acid derivatives
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
MXPA03005697A (es) 2000-12-22 2003-10-06 Glaxo Group Ltd Inhalador de dosis medida para xinafoato de salmeterol.
US20110301569A1 (en) 2001-01-20 2011-12-08 Gordon Wayne Dyer Methods and apparatus for the CVCS
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
MXPA04007899A (es) 2002-02-13 2004-10-15 Glaxo Group Ltd Compuestos de acido carboxilico para usarse como agentes tensoactivos.
GB0205327D0 (en) 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
US7754242B2 (en) * 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
US7279451B2 (en) * 2002-10-25 2007-10-09 Honeywell International Inc. Compositions containing fluorine substituted olefins
US20040152720A1 (en) * 2002-12-20 2004-08-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
WO2004110460A1 (fr) 2003-06-13 2004-12-23 Altana Pharma Ag Combinaison de formoterol et de ciclesonide
EP1654312B1 (fr) 2003-08-11 2014-01-15 Glaxo Group Limited Aerosol doseur pharmaceutique et procedes associes
US20080190418A1 (en) 2003-08-29 2008-08-14 Glaxo Group Limited Pharmaceutical Metered Dose Inhaler and Methods Relating Thereto
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
EP1744800B1 (fr) 2004-04-21 2016-06-22 Innovata Biomed Limited Inhalateur
US8148377B2 (en) 2007-02-11 2012-04-03 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
EP2384337A1 (fr) 2009-01-05 2011-11-09 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Moyens et procédé de traitement de maladies de déficience en anticorps sur la base de il-21 et de variants de il-21
JP2013512193A (ja) 2009-11-24 2013-04-11 ギリアード サイエンシーズ， インコーポレイテッド 慢性閉塞性肺疾患の処置のための吸入型ホスホマイシン／トブラマイシン
WO2011081937A1 (fr) 2009-12-15 2011-07-07 Gilead Sciences, Inc. Composés de type corticostéroïde-bêta-agoniste-antagoniste muscarinique pour applications thérapeutiques
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
WO2011143106A1 (fr) 2010-05-10 2011-11-17 Gilead Sciences, Inc. Composés pyrazolopyridiniques bifonctionnels
JP5807058B2 (ja) 2010-05-10 2015-11-10 ギリアード サイエンシーズ， インコーポレイテッド 二機能キノリン誘導体
BR112012030930A2 (pt) 2010-06-04 2017-07-11 Trifoilium Aps fatores de trevo (tff) para tratamento de doenças pulmonares crônicas.
SG188401A1 (en) 2010-09-09 2013-04-30 Trifoilium Aps Airway administration of angiogenesis inhibitors
GB201108039D0 (en) 2011-05-13 2011-06-29 Mexichem Amanco Holding Sa Compositions
EP2721036B1 (fr) 2011-06-15 2015-07-22 Takeda GmbH Nouveaux composés de 3,4,4a,10b-tétrahydro-1h-thiopyrano[4,3-c]isoquinoline
JP5980318B2 (ja) 2011-06-17 2016-08-31 タケダ ゲー・エム・ベー・ハーＴａｋｅｄａ ＧｍｂＨ 新規のフタラジノン−ピロロピリミジンカルボキサミド誘導体
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
GB201117621D0 (en) 2011-10-12 2011-11-23 Mexichem Amanco Holding Sa Compositions
GB201117619D0 (en) 2011-10-12 2011-11-23 Mexichem Amanco Holding Sa Compositions
EP3366680B1 (fr) 2012-05-29 2020-05-13 Parion Sciences, Inc. Amides aminés analogues de dendrimère possédant une activité de blocage du canal sodique pour le traitement de l' il sec et d'autres affections des muqueuses
ES2674665T3 (es) 2012-12-17 2018-07-03 Parion Sciences, Inc. Compuestos de 3,5-diamino-6-cloro-N-(N-(4-fenilbutilo)carbamimidoilo)-pirazina-2-carboxamida
RU2015129065A (ru) 2012-12-17 2017-01-25 Пэрион Сайенсиз, Инк. Производные хлор-пиразинкарбоксамида, обладающие активностью блокирования эпителиальных натриевых каналов
CN104995178B (zh) 2012-12-17 2018-06-26 帕里昂科学公司 3，5-二氨基-6-氯-n-(n-(4-苯基丁基)甲脒基)吡嗪-2-甲酰胺化合物
GB201306984D0 (en) 2013-04-17 2013-05-29 Mexichem Amanco Holding Sa Composition
EP3383366B2 (fr) 2015-12-04 2024-06-05 Mexichem Fluor S.A. de C.V. Composition pharmaceutique
CN113288869A (zh) 2016-09-19 2021-08-24 墨西哥氟石股份公司 药物组合物
CA3037107C (fr) 2016-09-19 2021-05-18 Mexichem Fluor S.A. De C.V. Compositions pharmaceutiques stables comprenant du salmeterol et du 1,1-difluoroethane (hfa 152a) pour utilisation dans des aerosols-doseurs
EP3607936B1 (fr) 2016-09-19 2023-11-08 Mexichem Fluor S.A. de C.V. Composition pharmaceutique comprenant glycopyrrolate
WO2018069210A1 (fr) 2016-10-10 2018-04-19 Takeda Gmbh Tétrahydrofuro [3,4-c] isoquinolines en tant qu'inhibiteurs de pde4

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB902590A (en) 1960-03-22 1962-08-01 Allied Chem Production of heptafluoropropane
DE1542076A1 (de) * 1966-04-21 1970-03-26 Colgate Palmolive Co Aerosol-Treibmittel
MX3864E (es) 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
US4405598A (en) 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
JPS5325284A (en) * 1976-08-19 1978-03-08 Daikin Ind Ltd Aerosol composition
US4352789A (en) 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
JPS5734174A (en) * 1980-08-11 1982-02-24 Toyo Aerosol Kogyo Kk Powdered aerosol composition
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
US4778674A (en) * 1986-05-28 1988-10-18 Richardson-Vicks Inc. Dry aerosol foam
EP0257915B1 (fr) 1986-08-11 1993-03-10 Innovata Biomed Limited Formulations pharmaceutiques contenant des microcapsules
DE3815480A1 (de) 1988-05-06 1989-11-16 Boehringer Ingelheim Kg Synergistische kombinationen und ihre verwendung als therapeutika
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
US6013245A (en) * 1995-01-26 2000-01-11 Glaxo Group Limited Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol

Also Published As

Publication number Publication date
NO923039L (no) 1992-07-31
CS26491A3 (en) 1991-09-15
HUT62456A (en) 1993-05-28
DE4003272A1 (de) 1991-08-08
PT96634B (pt) 1998-07-31
HU9202509D0 (en) 1992-10-28
FI923490A0 (fi) 1992-08-03
ZA91754B (en) 1992-10-28
EP0514415A1 (fr) 1992-11-25
NO302419B1 (no) 1998-03-02
US6413497B1 (en) 2002-07-02
YU49203B (sh) 2004-09-03
SI9110156B (sl) 1999-04-30
CA2075058C (fr) 2001-03-27
NO923039D0 (no) 1992-07-31
IE910351A1 (en) 1991-08-14
EP0514415B1 (fr) 1998-05-06
HRP940735A2 (en) 1997-06-30
IE910350A1 (en) 1991-08-14
ES2117964T3 (es) 1998-09-01
PT96634A (pt) 1991-10-31
HRP940735B1 (en) 1999-10-31
CZ286691B6 (cs) 2000-06-14
FI102905B1 (fi) 1999-03-15
SK280426B6 (sk) 2000-02-14
AU7211391A (en) 1991-08-21
FI923490L (fi) 1992-08-03
JPH05504160A (ja) 1993-07-01
CA2075058A1 (fr) 1991-08-04
JP3497161B2 (ja) 2004-02-16
SI9110156A (sl) 1998-04-30
HK1010786A1 (en) 1999-06-25
IL97028A (en) 1994-08-26
WO1991011495A1 (fr) 1991-08-08
NZ236973A (en) 1993-08-26
DE59108979D1 (de) 1998-06-10
AU650001B2 (en) 1994-06-09
YU15691A (sh) 1994-01-20
FI102905B (fi) 1999-03-15
IL97028A0 (en) 1992-03-29
ATE165863T1 (de) 1998-05-15
HU218784B (hu) 2000-12-28

Similar Documents

Publication Publication Date Title
DK0514415T3 (da) Drivgasblandinger og deres anvendelse i lægemiddelpræparater
DK0513099T3 (da) Nye drivgasser og deres anvendelse i lægemiddelpræparater
NO921012D0 (no) Farmasoeytiske preparater og deres anvendelse
NO943511D0 (no) Farmasöytiske preparater og anvendelse derav
DK623087D0 (da) Laegemiddelpraeparat og catecholderivater til brug ved fremstilling deraf
DK0527879T3 (da) Synergistiske terapeutiske præparater og fremgangsmåder.
DK130389D0 (da) Catecholderivater og farmaceutiske praeparater omfatende samme
DK349088A (da) Haerdelige blandinger og deres anvendelse
DK0455396T3 (da) Vandige gelpræparater og deres anvendelse.
DK4491A (da) Aclonifen-baserede herbicidblandinger og deres anvendelse
DK0425434T3 (da) Farvestofblandinger og deres anvendelse
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
DK296690A (da) Topisk, kosmetisk og farmaceutisk praeparat
DK650089D0 (da) Furanalkylketoner og farmaceutiske praeparater deraf
FI905825A7 (fi) Amfifiiliset peptidit ja niiden käyttö
DK633789D0 (da) Benzothiazol-derivater, deres fremstilling og anvendelse i laegemidler
DK489889D0 (da) Dihydropyridinamider, deres fremstilling og anvendelse i laegemidler
DK564189D0 (da) Insecticidt praeparat og insecticid aerosol
NO890816D0 (no) De-emulgeringsblandinger og fremgangsmaate ved fremstilling og anvendelse derav.
DK634089A (da) Polyhydroxybenzyloxypropanolaminer og deres anvendelse
NO892190L (no) Kompositt-materialer og deres anvendelse.
DK421589D0 (da) Flankerende peptider samt deres fremstilling og anvendelse
DK220389A (da) Synergistiske kombinationspraeparater og deres anvendelse som terapeutika
NO179907C (no) Benzokinoksaliner og farmasöytiske preparater inneholdende de samme
DK40292A (da) Dibenzofurancarboxamider og farmaceutiske praeparater indeholdende disse